News Stories

• Atlantic Dermatological Conference on Meeting Calendar

  The 89th strongAtlantic Dermatological Conference/strong hosted by the Dermatologic Society of Greater New York will be held April 27-29 at the Grand Hyatt Hotel, New York City. Register online at a href="http://www.DermSociety...  more >

• Brodalumab Moves Into Phase III for Moderate to Severe Psoriasis

  Results from a Phase II study that evaluated the efficacy and safety of brodalumab in patients with moderate to severe psoriasis, show a higher mean percentage improvement in Psoriasis Area and Severity Index (PASI) score comp...  more >

• Early Data Presented for Ixekizumab In Chronic Plaque Psoriasis

  Results for Eli Lilly and Company’s (NYSE: LLY) ixekizumab, an anti-IL-17 monoclonal antibody, show improved clinical symptoms in patients with moderate-to-severe plaque psoriasis. The randomized, double-blind, placebo-contro...  more >

• EHR iPad App Now Features Speech Recognition

  The EZ DERM EHR iPad app is now powered by the cloudbased Nuance Healthcare 360 | Development Platform. The speech recognition platform provides CPU intensive speech and language processing in the cloud. The app will also permi...  more >

• EMR Sales Grow 14 Percent in 2011

  Sales of electronic medical records (EMRs) showed stronger growth in 2011 than 2010, according to new data from Kalorama Information. In total, EMR sales grew 14.2 percent in 2011, according to Kalorama’s annual report. The r...  more >

• Intralesional PV-10 Induces Anti-Tumor Immunity

  Nonclinical research data by Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) on the immunologic mechanism of action of PV-10 confirms that PV-10 chemoablation of melanoma lesions leads to a systemic response and the induction of ...  more >

• Kythera Initiates Phase III Trials for Investigational Injectable

  Kythera has initiated two Phase III trials of ATX-101. The trials, known as REFINE-1 and REFINE-2 (Randomized Doubleblind Evaluation of Submental Fat Reduction IN ATX-101 TrEated Patients), will assess the efficacy, safety, and...  more >

• New Survey Reveals Attitudes Toward “Beautiful Tan”

  A new survey of more than 1,000 adults shows that while the majority acknowledged that they might be at risk for sun damage, tanned skin was still rated one of the most attractive skin features. In addition, though nearly six i...  more >

• Promiseb Shown Effective For Pediatric Seborrheic Dermatitis

  Results of a pilot study show that Promiseb Cream (Promius Pharma) applied topically twice daily for up to 14 days in pediatric patients is effective for seborrheic dermatitis. The study compared Promiseb Cream to Eucerin Cream...  more >

• Report: Patients See Doctors, Take Medications with Less Frequency

  Patients are visiting their physicians and using prescription drugs less often, according to a new report from the IMS Institute for Healthcare Informatics. The report, The Use of Medicines in the United States: Review of 2011,...  more >

• Vampire Facelift Found Effective with Fat Grafting

  A new study highlights the potential benefit of a plateletrich fibrin matrix preparation in combination with fat grafting procedures (Am J Cosmetic Surg, 2012; 29(1): 62-4). Using a small amount of the patient’s own blood, th...  more >